Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term pharmacotherapy for obesity and overweight.
Padwal R, Li SK, Lau DC. Padwal R, et al. Among authors: lau dc. Cochrane Database Syst Rev. 2004;2003(3):CD004094. doi: 10.1002/14651858.CD004094.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266516 Free PMC article. Review.
Long-term pharmacotherapy for obesity and overweight.
Padwal R, Li SK, Lau DC. Padwal R, et al. Among authors: lau dc. Cochrane Database Syst Rev. 2003;(4):CD004094. doi: 10.1002/14651858.CD004094. Cochrane Database Syst Rev. 2003. PMID: 14584004 Updated. Review.
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, Pedersen SD, Pietiläinen KH, Rubino D, Batterham RL. Lau DCW, et al. Lancet. 2021 Dec 11;398(10317):2160-2172. doi: 10.1016/S0140-6736(21)01751-7. Epub 2021 Nov 16. Lancet. 2021. PMID: 34798060 Clinical Trial.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.
Enebo LB, Berthelsen KK, Kankam M, Lund MT, Rubino DM, Satylganova A, Lau DCW. Enebo LB, et al. Among authors: lau dcw. Lancet. 2021 May 8;397(10286):1736-1748. doi: 10.1016/S0140-6736(21)00845-X. Epub 2021 Apr 22. Lancet. 2021. PMID: 33894838 Clinical Trial.
125 results